Efficacy and safety of anlotinib-based treatment in metastatic breast cancer patients

Overview of attention for article published in Frontiers in oncology, December 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 11 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 24,835 followers.

Efficacy and safety of anlotinib-based treatment in metastatic breast cancer patients https://t.co/VPE2qL8AeK https://t.co/27Tc0S1d7T

11 Dec 2022

Reply Repost Favourite

RT @FrontOncology: New research: Efficacy and safety of anlotinib-based treatment in metastatic breast cancer patients: Objective To evalu…

09 Dec 2022

Reply Repost Favourite

New research: Efficacy and safety of anlotinib-based treatment in metastatic breast cancer patients: Objective To evaluate the efficacy and safety of anlotinib-based treatment in metastatic breast cancer (MBC) patients with failure of standard… https://t.

09 Dec 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.